Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs.
Quinn K, Gullapalli RP, Merisko-Liversidge E, Goldbach E, Wong A, Liversidge GG, Hoffman W, Sauer JM, Bullock J, Tonn G. Quinn K, et al. Among authors: gullapalli rp. J Pharm Sci. 2012 Apr;101(4):1462-74. doi: 10.1002/jps.23034. Epub 2011 Dec 28. J Pharm Sci. 2012. PMID: 22213574
Soft gelatin capsules (softgels).
Gullapalli RP. Gullapalli RP. J Pharm Sci. 2010 Oct;99(10):4107-48. doi: 10.1002/jps.22151. J Pharm Sci. 2010. PMID: 20737624 Review.
Gelatin and Non-Gelatin Capsule Dosage Forms.
Gullapalli RP, Mazzitelli CL. Gullapalli RP, et al. J Pharm Sci. 2017 Jun;106(6):1453-1465. doi: 10.1016/j.xphs.2017.02.006. Epub 2017 Feb 14. J Pharm Sci. 2017. PMID: 28209365 Review.
Extemporaneous preparation strategy for early phase clinical studies.
Gullapalli RP, Mazzitelli CL, Charriez CM, Carpenter DJ, Crean RD, Carter B, Perera P. Gullapalli RP, et al. Int J Pharm. 2018 Oct 5;549(1-2):150-160. doi: 10.1016/j.ijpharm.2018.07.059. Epub 2018 Jul 25. Int J Pharm. 2018. PMID: 30055303 Clinical Trial.
131 results